The Valley Desk

NCT01156415 · Interventional trial

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Overall registry status Terminated

Phase 3

Conditions Major Depressive Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov